JBCHEPHARMJBCHEPHARMNSE
Chemicals & Pharmaceuticals Limited (“Company”)
As filed · Shareholders meeting
DistressDeterioratingCriticalmateriality 93 out of 100
What happened
FactChemicals & Pharmaceuticals Limited (“Company”). The NCLT convened Meeting of Equity Shareholders of the Company commenced at 02:00 p.m.
Why it matters
CapitSignal interpretationOnce an insolvency process is admitted, control of the company passes from the board to a resolution professional and equity ranks last in any recovery.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
RevisedEarlierFY25
India and CDMO business should constitute around 75% - 80% of total revenue in the mid-term
NowFY25
India business should continue to deliver market-beating growth; Focus on increasing chronic share to 60% in the mid to long-term
Change
FactTarget revision
Implication
CapitSignal interpretationThe earlier statement indicated that India and CDMO business would constitute around 75% - 80% of total revenue, while the current statement focuses solely on the India business aiming for a chronic share of 60%. This represents a material change in the target for the revenue contribution.
Watch next
Fact- Admission or rejection of the application by the tribunal
- Appointment of a resolution professional
- Claims admitted against the company
- By end of quarter 3, you should see that business growing at high single digit. (management committed by Q3 FY27)
- the second phase of our pipeline starts getting approvals from H2 of next financial year. (management committed by H2 FY27)
Evidence
- JB Chemicals & Pharmaceuticals Limited has informed the Exchange about proceedings of the NCLT convened meeting(opens the original filing in a new tab)
- Earlier statement · FY25
- Latest statement · FY25
How CapitSignal classified this
- Reasoning:
- INSOLVENCY base 93; explicit insolvency/default evidence present; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%